Adaptin Bio, Inc. is a biotechnology company developing novel therapies for oncology and central nervous system disorders with improved drug delivery to the brain and other tissues. The company’s proprietary Brain Bispecific T cell Engager (BRiTE) technology was developed by researchers at the Department of Neurosurgery at Duke University.
The company’s mission is to develop novel therapies to improve patient outcomes in difficult-to-treat cancers. For more information, visit www.adaptinbio.com.
Company Details
- Employees
- 1
- Address
- Charlotte, North Carolina, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.adaptinbio.com
- HQ
- Charlotte, North Carolina
Adaptin Bio, Inc. Questions
Adaptin Bio, Inc.'s website is http://www.adaptinbio.com
Adaptin Bio, Inc.'s LinkedIn profile is https://www.linkedin.com/company/adaptin-bio-inc
Adaptin Bio, Inc. has
1 employees.
View email and phone details for 1
employees at Adaptin Bio, Inc..
Adaptin Bio, Inc.'s industry is
Biotechnology Research
Adaptin Bio, Inc.'s top competitors are
Voyager Therapeutics, Inc.,
Summit Therapeutics, Inc.,
Rocket Pharmaceuticals,
Papillon Therapeutics,
Neurocrine Biosciences,
Poltreg S.a.,
Akeso Biopharma,
Zenas Biopharma,
Candid Therapeutics,
Poseida Therapeutics, Inc..
Adaptin Bio, Inc.'s categories are Biotechnology Research
